| Diane C Wolkoff, | |
|
3449 E Rezanof Dr, Kodiak, AK 99615-6952 | |
| (907) 486-9870 | |
| (907) 486-9898 |
| Full Name | Diane C Wolkoff |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 3449 E Rezanof Dr, Kodiak, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215196423 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 4743 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diane C Wolkoff, 3449 E Rezanof Dr, Kodiak, AK 99615-6952 Ph: (907) 486-9870 | Diane C Wolkoff, 3449 E Rezanof Dr, Kodiak, AK 99615-6952 Ph: (907) 486-9870 |
News Archive
A team led by scientists at The Scripps Research Institute (TSRI) has received a grant of more than $13 million from the National Institute of Allergy and Infectious Disease of the National Institutes of Health to study antibodies to the human immunodeficiency virus (HIV)-which will play an essential role in the creation of any effective vaccine against HIV.
While there has been much concern about the potential harm from transgender medical intervention (hormone therapy), a new study has found that transgender women who receive hormone therapy are more likely to quit or decrease smoking cigarettes as compared to the general population.
Continuing a commitment to the health and safety of its athletes, the Ultimate Fighting Championship announced today that all potential UFC and STRIKEFORCE signees will be subject to a mandatory pre-contract screening for performance-enhancing drugs. Beginning Jan. 1, 2012, all incoming athletes will be tested prior to finalizing a contract with the world's premier mixed martial arts organization.
Probiodrug AG today announced it has secured EUR 15 million additional financing for the ongoing development of its glutaminyl cyclase (QC) inhibitor program. The lead compound, PQ912, its first QC inhibitor, is in clinical development for the treatment of Alzheimer's disease.
Lyme disease is a growing threat in the U.S., with numbers that continue to rise despite increased awareness about the disease. "Little is being done to stop the spread of Lyme disease and to help those who are suffering from chronic Lyme," says Pat Smith, president of the all-volunteer national Lyme Disease Association, which funds research, educates the public, and provides scientific conferences for doctors.
› Verified 1 days ago
Mrs. Shana J Jones, RN General Practice Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-9800 Fax: 907-486-9898 | |
Mr. Mark Edward Withrow, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1818 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-6065 Fax: 907-486-2248 | |
Georgia J Blain, General Practice Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-9870 Fax: 907-486-9898 | |
Nadiya James, RN General Practice Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-9800 Fax: 907-486-9898 | |
Bettye Plyler, LPN General Practice Medicare: Not Enrolled in Medicare Practice Location: 3449 East Rezanof Drive, Kodiak, AK 99615 Phone: 907-486-9870 Fax: 907-486-9898 | |
Judith K Spoerer, General Practice Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-9870 Fax: 907-486-9898 |